Abstract

BackgroundHypothyroidism is a chronic condition of endocrine disorder and its precise molecular mechanism remains obscure. In spite of certain efficacy of thyroid hormone replacement therapy in treating hypothyroidism, it often results in other side effects because of its over-replacement, so it is still urgent to discover new modes of treatment for hypothyroidism. Sini decoction (SND) is a well-known formula of Traditional Chinese Medicine (TCM) and is considered as efficient agents against hypothyroidism. However, its holistic effect assessment and mechanistic understanding are still lacking due to its complex components.Methodology/Principal FindingsA urinary metabonomic method based on ultra performance liquid chromatography coupled to mass spectrometry was employed to explore global metabolic characters of hypothyroidism. Three typical hypothyroidism models (methimazole-, propylthiouracil- and thyroidectomy-induced hypothyroidism) were applied to elucidate the molecular mechanism of hypothyroidism. 17, 21, 19 potential biomarkers were identified with these three hypothyroidism models respectively, primarily involved in energy metabolism, amino acid metabolism, sphingolipid metabolism and purine metabolism. In order to avert the interference of drug interaction between the antithyroid drugs and SND, the thyroidectomy-induced hypothyroidism model was further used to systematically assess the therapeutic efficacy of SND on hypothyroidism. A time-dependent recovery tendency was observed in SND-treated group from the beginning of model to the end of treatment, suggesting that SND exerted a recovery effect on hypothyroidism in a time-dependent manner through partially regulating the perturbed metabolic pathways.Conclusions/SignificanceOur results showed that the metabonomic approach is instrumental to understand the pathophysiology of hypothyroidism and offers a valuable tool for systematically studying the therapeutic effects of SND on hypothyroidism.

Highlights

  • Hypothyroidism is a condition in which the body lacks sufficient thyroid hormone

  • Before the hypothyroidism models were established, there was no significant difference in body weight between control group (172.163.2 g), MMI group (171.462.9 g) and PTU group (173.563.4 g)

  • Body weight was markedly lower in MMI group (194.762.8 g; p,0.001) and PTU group (203.263.1 g; p,0.001) than in control group (251.263.6 g) after the antithyroid drug-induced hypothyroidism models were established

Read more

Summary

Introduction

Hypothyroidism is a condition in which the body lacks sufficient thyroid hormone. Some studies have shown that hypothyroidism may induce delayed skeletal development [3], cardiovascular diseases [4], secondary hypertension [5], deterioration of human reproductive health [6], and changes in the brain structure and function [7]. The main treatment for hypothyroidism at present is thyroid hormone replacement therapy [8,9]. There is an urgent need to seek new strategies for the management of hypothyroidism. In spite of certain efficacy of thyroid hormone replacement therapy in treating hypothyroidism, it often results in other side effects because of its over-replacement, so it is still urgent to discover new modes of treatment for hypothyroidism. Its holistic effect assessment and mechanistic understanding are still lacking due to its complex components

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call